查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1765431

全球经导管栓塞及阻塞设备市场

Transcatheter Embolization and Occlusion Devices
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 193 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

预计到 2030 年，全球经导管栓塞和阻塞设备市场规模将达到 68 亿美元

全球经导管栓塞和阻塞设备市场规模预计在2024年为46亿美元，预计到2030年将达到68亿美元，2024年至2030年的复合年增长率为6.6%。栓塞线圈是本报告分析的细分市场之一，预计其复合年增长率为7.1%，到分析期结束时规模将达到28亿美元。此外，栓塞辅助装置细分市场在分析期间的复合年增长率预计为5.9%。

美国市场规模估计为 13 亿美元，中国市场预期复合年增长率为 6.1%

美国经导管栓塞和阻塞设备市场规模预计在2024年达到13亿美元。作为世界第二大经济体，中国预计到2030年市场规模将达到10亿美元，在2024-2030年的分析期间内，复合年增长率为6.1%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间内，这两个市场的复合年增长率分别为6.2%和5.2%。在欧洲，预计德国市场的复合年增长率为5.4%。

全球经导管栓塞和阻塞设备市场—主要趋势和驱动因素摘要

什么是经导管栓塞和阻塞设备？为什么它们在医疗保健中很重要？

经导管栓塞和阻塞设备是用于阻塞和闭塞血管的医疗器械，主要用于介入放射学和微创手术等各种治疗应用。它们用于治疗动脉瘤、动静脉畸形 (AVM)、肿瘤、异常出血等。这些器械的主要目的是阻断流向目标区域的血流，从而促进治疗并降低手术过程中併发症的风险。这些器械在血管疾病管理中发挥关键作用，是现代医疗保健中必不可少的工具，为患者提供了一种与传统手术相比侵入性较小的治疗方法。

血管疾病的日益普及、介入技术的进步以及对微创手术日益增长的需求，推动了经导管栓塞和阻塞设备在全球范围内的普及。随着全球人口老化以及动脉瘤、癌症和周边血管疾病等疾病发生率的上升，对有效栓塞和封锁手术的需求日益增长。此外，影像技术和导管介入手术的进步提高了这些手术的安全性和有效性，鼓励医疗保健提供者采用经导管手术。人们越来越重视透过微创干预来改善患者预后，这推动了全球经导管栓塞和阻塞设备市场的扩张。

技术进步如何影响经导管栓塞和阻塞设备的发展？

技术进步显着改善了经导管栓塞和阻塞设备的设计和功能，从而改善了治疗效果并提高了医疗程序的效率。一项显着的创新是用于栓塞装置的生物可吸收和生物分解性材料的开发。这些先进的材料可以暂时闭塞血管，从而降低永久性植入相关的长期併发症风险。使用生物可吸收装置可以在癒合后恢復正常血流，这在治疗血管病变和其他病症方面具有重大优势。

推动市场发展的另一个关键技术进步是经导管治疗与先进影像技术的结合。锥状射束电脑断层扫描 (CBCT) 和术中超音波等技术正被用于提高栓塞手术的可视化程度和精准度。这些改进的影像能力使我们能够更好地评估血管解剖结构，更精确地放置栓塞装置，最终提高手术成功率。先进影像技术与经导管技术的结合正在彻底改变栓塞和闭塞手术的方法，使栓塞治疗对患者更安全、更有效。

此外，混合型和多功能设备的开发正在扩展经导管栓塞系统的功能。製造商越来越注重开发具有多种功能的设备，例如在输送栓塞剂的同时进行其他治疗性介入。这种功能整合简化了流程，减少了对多台设备的需求，最终提高了效率并改善了患者照护。对多功能性和创新性的重视正在塑造经导管栓塞和阻塞设备的未来，为医疗保健专业人员提供更多功能齐全的工具来应对复杂的血管疾病。

是什么推动了各种医疗保健环境中采用经导管栓塞和阻塞设备？

经导管栓塞和阻塞设备的普及受多种关键因素驱动，包括血管疾病盛行率的不断上升、对微创手术的需求不断增长，以及对患者安全和治疗效果的日益关注。其中一个主要驱动因素是动脉瘤和周边动脉疾病等血管疾病的盛行率不断上升，这些疾病需要有效的治疗方案。人口老化和慢性病发病率的不断上升，推动了对能够安全有效地管理这些疾病的经导管解决方案的需求。医疗保健提供者越来越依赖栓塞和阻塞设备来治疗患者，从而推动了市场应用。

影响经导管栓塞和阻塞设备应用的另一个关键因素是微创手术需求的持续成长。患者和医护人员越来越青睐那些能够减少手术创伤、加快恢復时间并最大程度减少併发症的技术。经导管手术具有显着优势，包括缩短住院时间和加快恢復速度，使其成为对病患和医护人员都极具吸引力的选择。这种向微创方法的转变推动了栓塞和阻塞设备的普及，这些装置为治疗血管疾病提供了一种无需开放性手术的有效解决方案。

此外，对病人安全和临床疗效改善的日益关注，推动了经导管栓塞和阻塞设备在各种医疗环境中的应用。随着医疗保健提供者优先使用能够增强安全性并最大程度降低风险的装置，对先进栓塞和封堵解决方案的需求也日益增长。更安全、更有效的装置的开发，以及改进的使用训练和通讯协定，正在促进患者疗效的改善和满意度的提升。对安全性和优质照护的关注，正在推动医疗机构更广泛地采用经导管栓塞和阻塞设备。

推动全球经导管栓塞和阻塞设备市场成长的因素是什么？

全球经导管栓塞和阻塞设备市场的成长受到多种因素的推动，包括医疗基础设施投资的增加、医疗技术的不断进步以及个人化医疗趋势的兴起。其中一个主要成长要素是医疗基础设施投资的增加，旨在改善患者照护并扩大先进医疗手段的可近性。各国政府和医疗机构正在投入资源升级医疗设施，尤其是在新兴经济体，导致介入放射学和栓塞治疗的应用日益普及。对有效治疗血管疾病的需求正在推动医疗基础设施投资的增加，从而支持经导管栓塞和阻塞设备市场的成长。

市场成长的另一个主要驱动力是医疗技术的不断进步，这些技术提高了经导管手术的有效性和安全性。创新栓塞材料、改进的影像技术和先进的输送系统的开发，使医疗保健提供者能够更精确、更可靠地执行手术。随着製造商持续投入研发，开发能够改善性能和患者预后的新产品，预计对经导管栓塞和阻塞设备的需求将会增加。这种对创新的关注有助于企业在竞争中脱颖而出，从而推动市场成长。

此外，个人化医疗的日益增长趋势也推动了经导管栓塞和阻塞设备市场的成长。随着医疗保健逐渐转向更个人化的治疗方法，对有针对性且有效的栓塞解决方案的需求日益增长。经导管装置可以根据患者独特的解剖和临床特征进行定制，以满足其特定需求。随着医疗保健专业人员寻求提高治疗效果并改善患者预后，这种对个人化治疗的关注正在推动经导管解决方案的普及。

此外，医疗专业人员和患者对微创技术及其益处的认识不断提高，也影响经导管栓塞和阻塞设备市场的成长。随着越来越多的从业者认识到使用经导管技术治疗血管疾病的益处，预计这些装置的采用率将会增加。对改善手术技术和病人安全的重视，正推动医疗机构投资先进的经导管栓塞和阻塞设备。随着这些因素继续塑造市场格局，医疗基础设施投资的增加、医疗技术的不断进步以及个人化医疗的日益增长，将推动市场格局的强劲增长。

部分

产品类型（栓塞线圈、栓塞辅助装置、栓塞颗粒、液体导流装置、液体栓塞、配件）

受访公司范例

  • Abbott Laboratories
  • Boston Scientific Corporation
  • BTG International Ltd.
  • Cook Medical LLC
  • Edwards Lifesciences Corporation
  • Johnson & Johnson
  • Medtronic PLC
  • Merit Medical Systems, Inc.
  • Penumbra, Inc.
  • Pfizer, Inc.
  • Sirtex Medical Limited
  • Stryker Corporation
  • Terumo Corporation

人工智慧集成

我们正在利用可操作的专家内容和人工智慧工具来改变市场和竞争情报。

Global 特定产业SLM 的典型规范，而是建立了一个来自全球专家的精选内容库，其中包括视讯录影、部落格、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

全球产业分析师根据公司总部所在国家、製造地、进出口状况（成品和原始OEM）预测其竞争态势的变化。这种复杂且多面向的市场动态预计将以多种方式影响竞争对手，包括销货成本成本 (COGS) 上升、盈利下降、供应链重组以及其他微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

  • 市场概览
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 其他欧洲国家
  • 亚太地区
  • 其他地区

第四章 竞赛

简介目录
Product Code: MCP16866

Global Transcatheter Embolization and Occlusion Devices Market to Reach US$6.8 Billion by 2030

The global market for Transcatheter Embolization and Occlusion Devices estimated at US$4.6 Billion in the year 2024, is expected to reach US$6.8 Billion by 2030, growing at a CAGR of 6.6% over the analysis period 2024-2030. Embolization Coils, one of the segments analyzed in the report, is expected to record a 7.1% CAGR and reach US$2.8 Billion by the end of the analysis period. Growth in the Coiling Assist Devices segment is estimated at 5.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.3 Billion While China is Forecast to Grow at 6.1% CAGR

The Transcatheter Embolization and Occlusion Devices market in the U.S. is estimated at US$1.3 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.0 Billion by the year 2030 trailing a CAGR of 6.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 6.2% and 5.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.4% CAGR.

Global Transcatheter Embolization and Occlusion Devices Market - Key Trends & Drivers Summarized

What Are Transcatheter Embolization and Occlusion Devices and Why Are They Critical in Medical Procedures?

Transcatheter embolization and occlusion devices are medical instruments used to block or occlude blood vessels in various therapeutic applications, primarily in interventional radiology and minimally invasive surgery. These devices include a range of products such as embolic agents (coils, particles, and gels) and occlusion balloons, which are employed to treat conditions like aneurysms, arteriovenous malformations (AVMs), tumors, and abnormal bleeding. The primary purpose of these devices is to prevent blood flow to targeted areas, thereby facilitating treatment and reducing the risk of complications during surgical procedures. Their critical role in managing vascular conditions makes them essential tools in modern healthcare, offering patients less invasive treatment options compared to traditional surgery.

The global adoption of transcatheter embolization and occlusion devices is driven by the increasing prevalence of vascular diseases, advancements in interventional techniques, and the growing demand for minimally invasive procedures. As the global population ages and the incidence of conditions such as aneurysms, cancer, and peripheral vascular disease rises, the need for effective embolization and occlusion solutions has become more pronounced. Additionally, ongoing advancements in imaging technologies and catheter-based techniques have enhanced the safety and efficacy of these procedures, encouraging healthcare providers to adopt transcatheter methods. The emphasis on improving patient outcomes through less invasive interventions is propelling the expansion of the global transcatheter embolization and occlusion devices market.

How Are Technological Advancements Shaping the Development of Transcatheter Embolization and Occlusion Devices?

Technological advancements are significantly enhancing the design and functionality of transcatheter embolization and occlusion devices, leading to improved outcomes and greater efficiency in medical procedures. One notable innovation is the development of bioresorbable and biodegradable materials for embolic devices. These advanced materials allow for temporary occlusion of blood vessels, reducing the risk of long-term complications associated with permanent implants. The use of bioresorbable devices enables the restoration of normal blood flow once healing has occurred, providing a significant advantage in managing vascular lesions and other conditions.

Another key technological advancement driving the market is the integration of advanced imaging techniques with transcatheter procedures. Technologies such as cone beam computed tomography (CBCT) and intraoperative ultrasound are being utilized to enhance visualization and precision during embolization procedures. This improved imaging capability allows for better assessment of vascular anatomy and more accurate placement of embolic devices, ultimately leading to increased procedural success rates. The combination of advanced imaging and transcatheter techniques is revolutionizing the approach to embolization and occlusion, making these devices safer and more effective for patients.

Furthermore, the development of hybrid and multifunctional devices is expanding the capabilities of transcatheter embolization systems. Manufacturers are increasingly focusing on creating devices that can perform multiple functions, such as delivering embolic agents while simultaneously providing access for other therapeutic interventions. This integration of functions can streamline procedures and reduce the need for multiple devices, ultimately enhancing efficiency and improving patient care. The emphasis on multifunctionality and innovation is shaping the future of transcatheter embolization and occlusion devices, providing healthcare professionals with more versatile tools to address complex vascular conditions.

What Factors Are Driving the Adoption of Transcatheter Embolization and Occlusion Devices Across Various Healthcare Settings?

The adoption of transcatheter embolization and occlusion devices is being driven by several key factors, including the increasing prevalence of vascular diseases, the rising demand for minimally invasive procedures, and the growing focus on patient safety and outcomes. One of the primary drivers is the increasing prevalence of vascular diseases, such as aneurysms and peripheral artery disease, which require effective treatment options. As the aging population and the incidence of chronic diseases continue to rise, the demand for transcatheter solutions that can safely and effectively manage these conditions is escalating. Healthcare providers are increasingly relying on embolization and occlusion devices to treat patients, thereby driving market adoption.

Another significant factor influencing the adoption of transcatheter embolization and occlusion devices is the rising demand for minimally invasive procedures. Patients and healthcare professionals are increasingly favoring techniques that reduce surgical trauma, shorten recovery times, and minimize complications. Transcatheter procedures offer significant benefits, including reduced hospital stays and faster recuperation, making them appealing options for both patients and providers. This shift towards minimally invasive approaches is driving the adoption of embolization and occlusion devices, as they provide effective solutions for treating vascular issues without the need for open surgery.

Moreover, the growing focus on patient safety and improved clinical outcomes is driving the adoption of transcatheter embolization and occlusion devices across various healthcare settings. As healthcare providers prioritize the use of devices that enhance safety and minimize risks, the demand for advanced embolization and occlusion solutions is increasing. The development of safer and more effective devices, along with improved training and protocols for their use, is contributing to better patient outcomes and higher satisfaction rates. This emphasis on safety and quality care is encouraging healthcare facilities to adopt transcatheter embolization and occlusion devices more widely.

What Is Driving the Growth of the Global Transcatheter Embolization and Occlusion Devices Market?

The growth in the global Transcatheter Embolization and Occlusion Devices market is driven by several factors, including rising investments in healthcare infrastructure, increasing advancements in medical technologies, and the growing trend towards personalized medicine. One of the primary growth drivers is the rising investment in healthcare infrastructure aimed at improving patient care and expanding access to advanced medical treatments. Governments and healthcare organizations are increasingly allocating resources to upgrade medical facilities, particularly in emerging economies, leading to an increased adoption of interventional radiology and embolization techniques. The demand for effective treatment of vascular conditions is driving investments in healthcare infrastructure, thereby supporting the growth of the transcatheter embolization and occlusion devices market.

Another significant driver of market growth is the increasing advancements in medical technologies that enhance the efficacy and safety of transcatheter procedures. The development of innovative embolization materials, improved imaging technologies, and advanced delivery systems is enabling healthcare providers to perform procedures with greater precision and confidence. As manufacturers continue to invest in R&D and develop new products that offer improved performance and patient outcomes, the demand for transcatheter embolization and occlusion devices is expected to rise. This focus on innovation is fostering market growth as companies seek to differentiate their offerings in a competitive landscape.

Moreover, the growing trend towards personalized medicine is supporting the growth of the transcatheter embolization and occlusion devices market. As healthcare moves towards more individualized treatment approaches, the need for targeted and effective embolization solutions is becoming increasingly important. Transcatheter devices can be tailored to meet the specific needs of patients, taking into account their unique anatomical and clinical characteristics. This focus on personalized care is driving the adoption of transcatheter solutions, as healthcare providers seek to enhance treatment efficacy and improve patient outcomes.

Furthermore, the increasing awareness of minimally invasive techniques and their benefits among healthcare providers and patients is influencing the growth of the transcatheter embolization and occlusion devices market. As more practitioners recognize the advantages of using transcatheter methods to treat vascular conditions, the adoption of these devices is expected to increase. The emphasis on improving surgical techniques and patient safety is driving healthcare facilities to invest in advanced transcatheter embolization and occlusion devices. As these factors continue to shape the market landscape, the transcatheter embolization and occlusion devices market is poised for robust growth, driven by rising investments in healthcare infrastructure, increasing advancements in medical technologies, and a growing trend towards personalized medicine.

SCOPE OF STUDY:

The report analyzes the Transcatheter Embolization and Occlusion Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Embolization Coils, Coiling Assist Devices, Embolization Particles, Flow Diverting Devices, Liquid Embolics, Accessories)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 44 Featured) -

  • Abbott Laboratories
  • Boston Scientific Corporation
  • BTG International Ltd.
  • Cook Medical LLC
  • Edwards Lifesciences Corporation
  • Johnson & Johnson
  • Medtronic PLC
  • Merit Medical Systems, Inc.
  • Penumbra, Inc.
  • Pfizer, Inc.
  • Sirtex Medical Limited
  • Stryker Corporation
  • Terumo Corporation

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Transcatheter Embolization and Occlusion Devices - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Vascular Disorders and Aneurysms Drives Demand for Transcatheter Embolization and Occlusion Devices
    • Increased Adoption of Minimally Invasive Surgeries Expands Addressable Market for Transcatheter Embolization Devices
    • Surge in Demand for Transcatheter Embolization Devices in Cancer and Tumor Treatments Fuels Market Growth
    • Increased Use of Transcatheter Embolization Devices in Trauma and Emergency Care Settings Fuels Market Expansion
    • Technological Innovations in Bioabsorbable and Biocompatible Embolic Devices Propel Market Growth
    • Growing Use of Transcatheter Embolization Devices in Stroke Management and Neurovascular Interventions Strengthens Business Case
    • Surge in Adoption of Transcatheter Occlusion Devices in Congenital Heart Defect Treatments Fuels Market Demand
    • Rising Adoption of Transcatheter Devices in Liver and Kidney Tumor Embolization Expands Market Opportunities
    • Rising Use of Transcatheter Embolization Devices in Postpartum Hemorrhage and Uterine Fibroid Embolization Strengthens Business Case
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Transcatheter Embolization and Occlusion Devices Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Transcatheter Embolization and Occlusion Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Transcatheter Embolization and Occlusion Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Transcatheter Embolization and Occlusion Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Embolization Coils by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Embolization Coils by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Embolization Coils by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Coiling Assist Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Coiling Assist Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Coiling Assist Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Embolization Particles by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Embolization Particles by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Embolization Particles by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Flow Diverting Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Flow Diverting Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Flow Diverting Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Liquid Embolics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Liquid Embolics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Liquid Embolics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Accessories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Accessories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Accessories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Transcatheter Embolization and Occlusion Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Transcatheter Embolization and Occlusion Devices by Product Type - Embolization Coils, Coiling Assist Devices, Embolization Particles, Flow Diverting Devices, Liquid Embolics and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Transcatheter Embolization and Occlusion Devices by Product Type - Embolization Coils, Coiling Assist Devices, Embolization Particles, Flow Diverting Devices, Liquid Embolics and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: USA 15-Year Perspective for Transcatheter Embolization and Occlusion Devices by Product Type - Percentage Breakdown of Value Sales for Embolization Coils, Coiling Assist Devices, Embolization Particles, Flow Diverting Devices, Liquid Embolics and Accessories for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Transcatheter Embolization and Occlusion Devices by Product Type - Embolization Coils, Coiling Assist Devices, Embolization Particles, Flow Diverting Devices, Liquid Embolics and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Canada Historic Review for Transcatheter Embolization and Occlusion Devices by Product Type - Embolization Coils, Coiling Assist Devices, Embolization Particles, Flow Diverting Devices, Liquid Embolics and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: Canada 15-Year Perspective for Transcatheter Embolization and Occlusion Devices by Product Type - Percentage Breakdown of Value Sales for Embolization Coils, Coiling Assist Devices, Embolization Particles, Flow Diverting Devices, Liquid Embolics and Accessories for the Years 2015, 2025 & 2030
  • JAPAN
    • Transcatheter Embolization and Occlusion Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 29: Japan Recent Past, Current & Future Analysis for Transcatheter Embolization and Occlusion Devices by Product Type - Embolization Coils, Coiling Assist Devices, Embolization Particles, Flow Diverting Devices, Liquid Embolics and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Japan Historic Review for Transcatheter Embolization and Occlusion Devices by Product Type - Embolization Coils, Coiling Assist Devices, Embolization Particles, Flow Diverting Devices, Liquid Embolics and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: Japan 15-Year Perspective for Transcatheter Embolization and Occlusion Devices by Product Type - Percentage Breakdown of Value Sales for Embolization Coils, Coiling Assist Devices, Embolization Particles, Flow Diverting Devices, Liquid Embolics and Accessories for the Years 2015, 2025 & 2030
  • CHINA
    • Transcatheter Embolization and Occlusion Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 32: China Recent Past, Current & Future Analysis for Transcatheter Embolization and Occlusion Devices by Product Type - Embolization Coils, Coiling Assist Devices, Embolization Particles, Flow Diverting Devices, Liquid Embolics and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: China Historic Review for Transcatheter Embolization and Occlusion Devices by Product Type - Embolization Coils, Coiling Assist Devices, Embolization Particles, Flow Diverting Devices, Liquid Embolics and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: China 15-Year Perspective for Transcatheter Embolization and Occlusion Devices by Product Type - Percentage Breakdown of Value Sales for Embolization Coils, Coiling Assist Devices, Embolization Particles, Flow Diverting Devices, Liquid Embolics and Accessories for the Years 2015, 2025 & 2030
  • EUROPE
    • Transcatheter Embolization and Occlusion Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 35: Europe Recent Past, Current & Future Analysis for Transcatheter Embolization and Occlusion Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 36: Europe Historic Review for Transcatheter Embolization and Occlusion Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: Europe 15-Year Perspective for Transcatheter Embolization and Occlusion Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 38: Europe Recent Past, Current & Future Analysis for Transcatheter Embolization and Occlusion Devices by Product Type - Embolization Coils, Coiling Assist Devices, Embolization Particles, Flow Diverting Devices, Liquid Embolics and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Europe Historic Review for Transcatheter Embolization and Occlusion Devices by Product Type - Embolization Coils, Coiling Assist Devices, Embolization Particles, Flow Diverting Devices, Liquid Embolics and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: Europe 15-Year Perspective for Transcatheter Embolization and Occlusion Devices by Product Type - Percentage Breakdown of Value Sales for Embolization Coils, Coiling Assist Devices, Embolization Particles, Flow Diverting Devices, Liquid Embolics and Accessories for the Years 2015, 2025 & 2030
  • FRANCE
    • Transcatheter Embolization and Occlusion Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 41: France Recent Past, Current & Future Analysis for Transcatheter Embolization and Occlusion Devices by Product Type - Embolization Coils, Coiling Assist Devices, Embolization Particles, Flow Diverting Devices, Liquid Embolics and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: France Historic Review for Transcatheter Embolization and Occlusion Devices by Product Type - Embolization Coils, Coiling Assist Devices, Embolization Particles, Flow Diverting Devices, Liquid Embolics and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: France 15-Year Perspective for Transcatheter Embolization and Occlusion Devices by Product Type - Percentage Breakdown of Value Sales for Embolization Coils, Coiling Assist Devices, Embolization Particles, Flow Diverting Devices, Liquid Embolics and Accessories for the Years 2015, 2025 & 2030
  • GERMANY
    • Transcatheter Embolization and Occlusion Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 44: Germany Recent Past, Current & Future Analysis for Transcatheter Embolization and Occlusion Devices by Product Type - Embolization Coils, Coiling Assist Devices, Embolization Particles, Flow Diverting Devices, Liquid Embolics and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Germany Historic Review for Transcatheter Embolization and Occlusion Devices by Product Type - Embolization Coils, Coiling Assist Devices, Embolization Particles, Flow Diverting Devices, Liquid Embolics and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: Germany 15-Year Perspective for Transcatheter Embolization and Occlusion Devices by Product Type - Percentage Breakdown of Value Sales for Embolization Coils, Coiling Assist Devices, Embolization Particles, Flow Diverting Devices, Liquid Embolics and Accessories for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 47: Italy Recent Past, Current & Future Analysis for Transcatheter Embolization and Occlusion Devices by Product Type - Embolization Coils, Coiling Assist Devices, Embolization Particles, Flow Diverting Devices, Liquid Embolics and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Italy Historic Review for Transcatheter Embolization and Occlusion Devices by Product Type - Embolization Coils, Coiling Assist Devices, Embolization Particles, Flow Diverting Devices, Liquid Embolics and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Italy 15-Year Perspective for Transcatheter Embolization and Occlusion Devices by Product Type - Percentage Breakdown of Value Sales for Embolization Coils, Coiling Assist Devices, Embolization Particles, Flow Diverting Devices, Liquid Embolics and Accessories for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Transcatheter Embolization and Occlusion Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 50: UK Recent Past, Current & Future Analysis for Transcatheter Embolization and Occlusion Devices by Product Type - Embolization Coils, Coiling Assist Devices, Embolization Particles, Flow Diverting Devices, Liquid Embolics and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: UK Historic Review for Transcatheter Embolization and Occlusion Devices by Product Type - Embolization Coils, Coiling Assist Devices, Embolization Particles, Flow Diverting Devices, Liquid Embolics and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: UK 15-Year Perspective for Transcatheter Embolization and Occlusion Devices by Product Type - Percentage Breakdown of Value Sales for Embolization Coils, Coiling Assist Devices, Embolization Particles, Flow Diverting Devices, Liquid Embolics and Accessories for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 53: Rest of Europe Recent Past, Current & Future Analysis for Transcatheter Embolization and Occlusion Devices by Product Type - Embolization Coils, Coiling Assist Devices, Embolization Particles, Flow Diverting Devices, Liquid Embolics and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Rest of Europe Historic Review for Transcatheter Embolization and Occlusion Devices by Product Type - Embolization Coils, Coiling Assist Devices, Embolization Particles, Flow Diverting Devices, Liquid Embolics and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Rest of Europe 15-Year Perspective for Transcatheter Embolization and Occlusion Devices by Product Type - Percentage Breakdown of Value Sales for Embolization Coils, Coiling Assist Devices, Embolization Particles, Flow Diverting Devices, Liquid Embolics and Accessories for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Transcatheter Embolization and Occlusion Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 56: Asia-Pacific Recent Past, Current & Future Analysis for Transcatheter Embolization and Occlusion Devices by Product Type - Embolization Coils, Coiling Assist Devices, Embolization Particles, Flow Diverting Devices, Liquid Embolics and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Asia-Pacific Historic Review for Transcatheter Embolization and Occlusion Devices by Product Type - Embolization Coils, Coiling Assist Devices, Embolization Particles, Flow Diverting Devices, Liquid Embolics and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Asia-Pacific 15-Year Perspective for Transcatheter Embolization and Occlusion Devices by Product Type - Percentage Breakdown of Value Sales for Embolization Coils, Coiling Assist Devices, Embolization Particles, Flow Diverting Devices, Liquid Embolics and Accessories for the Years 2015, 2025 & 2030
  • REST OF WORLD
    • TABLE 59: Rest of World Recent Past, Current & Future Analysis for Transcatheter Embolization and Occlusion Devices by Product Type - Embolization Coils, Coiling Assist Devices, Embolization Particles, Flow Diverting Devices, Liquid Embolics and Accessories - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Rest of World Historic Review for Transcatheter Embolization and Occlusion Devices by Product Type - Embolization Coils, Coiling Assist Devices, Embolization Particles, Flow Diverting Devices, Liquid Embolics and Accessories Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Rest of World 15-Year Perspective for Transcatheter Embolization and Occlusion Devices by Product Type - Percentage Breakdown of Value Sales for Embolization Coils, Coiling Assist Devices, Embolization Particles, Flow Diverting Devices, Liquid Embolics and Accessories for the Years 2015, 2025 & 2030

IV. COMPETITION